Eli Lilly’s direct drug sales alone may not upend the industry, but others could follow suit

CNBC January 5, 2024
Annika Kim Constantino

Key Points

– Eli Lilly is shaking up the pharmaceutical industry with a new website offering telehealth prescriptions and direct home delivery of certain drugs, such as weight loss treatments, to expand patient access.

– The company’s direct-to-consumer push won’t necessarily upend the pharmaceutical industry and the traditional prescription drug supply chain, according to some analysts.

– But other drugmakers could follow suit with their own direct-to-consumer models and add pressure on what critics call a complex pharmaceutical industry.

Eli Lilly is shaking up the pharmaceutical industry with a new website offering telehealth prescriptions and direct home delivery of certain drugs, including its red-hot weight loss treatment Zepbound, to expand patient access.

The company’s direct-to-consumer push announced Thursday,...

Today's Sponsors

Today's Sponsor